进展期胃癌腹腔镜与开腹D2胃切除术随机对照试验短期结局
该随机对照试验纳入328例术前临床T2-3N0-3M0胃癌患者,排除6例未切除者后,322例随机分为腹腔镜组(162例)与开腹组(160例),均行D2淋巴结清扫。腹腔镜组总体并发症率11.72%,开腹组14.38%(P=0.512),两组均无死亡,提示在有经验中心腹腔镜D2胃切除术安全可行。
要点
- 腹腔镜组与开腹组总体并发症率分别为11.72%和14.38%,差异无统计学意义(P=0.512)。
- 两组均无死亡病例,腹腔镜组中转开腹率为3.70%。
- 在有经验中心,腹腔镜D2胃切除术治疗局部进展期胃癌安全可行。
核心结论
- 腹腔镜D2胃切除术治疗局部进展期胃癌的短期结果安全可行,但需在有经验中心开展。
研究设计与样本
- 前瞻性随机对照试验,比较腹腔镜与开腹D2胃切除术治疗局部进展期胃癌的技术安全性和肿瘤可行性。
- 2010年1月至2012年6月共纳入328例术前临床T2-3N0-3M0胃癌患者,排除6例未切除者后,322例随机分为腹腔镜组(162例)和开腹组(160例)。
- 术后并发症率和死亡率基于改良意向性分析。
主要发现
- 腹腔镜组总体并发症率为11.72%,开腹组为14.38%(P=0.512)。
- 两组均无死亡病例。
- 腹腔镜组6例(3.70%)中转开腹。
- 全部患者行D2淋巴结清扫,其中近端胃切除18例(5.59%),远端胃切除196例(60.87%),全胃切除108例(33.54%)。
临床怎么用
- 在有经验中心,可考虑将腹腔镜D2胃切除术作为局部进展期胃癌的治疗选择之一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopy-assisted gastrectomy (LAG) has gained acceptance as one of the best treatments for early gastric cancer. However, the application of LAG with D2 lymph node dissection in patients with locally advanced gastric cancer (AGC) remains controversial. METHODS: We launched a prospective randomized controlled trial comparing laparoscopic and open gastrectomy with D2 lymph node dissection for locally AGC to evaluate technical safety and oncologic feasibility. The postoperative morbidity and mortality rates were based on the modified intention-to-treat analysis. RESULTS: Between January 2010 and June 2012, a total of 328 patients with preoperative clinical stage T2-3N0-3M0 gastric cancer were enrolled in the trial. Six patients with unresected AGC were excluded, and the remaining 322 patients were randomized to the laparoscopic group (162 patients) or the open group (160 patients) for radical surgery. All patients underwent D2 lymph node dissection including 18 (5.59%) proximal gastrectomies, 196 (60.87%) distal gastrectomies, and 108 (33.54%) total gastrectomies. Six patients (3.70%) in the LAG group were converted to open procedures. The overall complication rate was 11.72% in the LAG group and 14.38% in the open group (P = 0.512). No mortality occurred in either group. CONCLUSIONS: The short-term results of the current study suggest that LAG with D2 lymph node dissection is a safe and feasible procedure in treating patients with locally AGC in experienced centers.
引用
- Shi Y, Xu X, Zhao Y, et al. Short-term surgical outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer. Surg Endosc. 2017. PMID: 29234941. doi:10.1007/s00464-017-5942-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。